Literature DB >> 2961786

Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.

M J Mansfield1, C R Rudlin, J F Crigler, K A Karol, J D Crawford, P A Boepple, W F Crowley.   

Abstract

Suppression of gonadal sex steroid secretion in children with central precocious puberty (CPP) by LHRH analogs affords an opportunity to study sex steroid modulation of GH and somatomedin-C (Sm-C) secretion and to examine the role of GH and Sm-C in pubertal and prepubertal statural growth. Nocturnal serum GH and plasma Sm-C levels were measured in 10 preadrenarchal girls [mean age, 3.0 +/- 0.6] ( +/- SEM) yr with CPP before and during 2 yr of LHRH analog-induced gonadal suppression. Their mean height velocity, initially 4.6 +/- 0.6 ( +/- SEM) SD above the mean for chronological age, decreased to -0.1 +/- 0.4 SD during 12-24 months of ovarian suppression (P less than 0.00005). The mean peak nocturnal plasma GH level was 22.5 +/- 5.4 ( +/- SEM) micrograms/L during puberty, and it decreased to 10.2 +/- 2.1 micrograms/L after 3 months of suppression of gonadarche. This decrease persisted throughout the 2 yr of gonadal suppression (P less than 0.05). The reduction in GH secretion was accompanied by a decrease in mean plasma Sm-C levels from 3.5 +/- 0.7 to 1.5 +/- 0.2 U/mL after 3 months of suppression of gonadal sex steroids, which persisted during 2 yr of gonadal suppression (P less than 0.01). Suppression of ovarian function in girls with CPP results in decreased height velocity. This slowing of growth occurs in association with decreased nocturnal serum GH and plasma Sm-C levels, suggesting that acceleration of growth during puberty is partially mediated by sex steroid-induced augmentation of GH secretion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2961786     DOI: 10.1210/jcem-66-1-3

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Insulin-like growth factor-1 increases bone calcium accumulation only during rapid growth in female rats.

Authors:  Qinmin Zhang; Meryl E Wastney; Clifford J Rosen; Wesley G Beamer; Connie M Weaver
Journal:  J Nutr       Date:  2011-09-28       Impact factor: 4.798

Review 2.  Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.

Authors:  J D Veldhuis; W S Evans; C Y Bowers; S Anderson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

Review 3.  Regulation of insulin-like growth factors by antiestrogen.

Authors:  R Winston; P C Kao; D T Kiang
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 4.  Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.

Authors:  L B Barradell; D McTavish
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

5.  Precocious puberty in girls: early diagnosis of a slowly progressing variant.

Authors:  M Fontoura; R Brauner; C Prevot; R Rappaport
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

6.  Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism.

Authors:  G Del Rio; C Carani; A Velardo; G Zizzo; M Procopio; F Coletta; P Marrama; E Ghigo
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

Review 7.  Obesity and the pubertal transition in girls and boys.

Authors:  Christine M Burt Solorzano; Christopher R McCartney
Journal:  Reproduction       Date:  2010-09       Impact factor: 3.906

8.  Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.

Authors:  P W Lu; C T Cowell; M Jimenez; J M Simpson; M Silink
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

Review 9.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 10.  Pros and cons of GnRHa treatment for early puberty in girls.

Authors:  Ruben H Willemsen; Daniela Elleri; Rachel M Williams; Ken K Ong; David B Dunger
Journal:  Nat Rev Endocrinol       Date:  2014-04-08       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.